Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1208 of 6351
-
Can donated plasma from COVID-19 survivors speed up recovery?
Disease control CompletedThe coronavirus disease 2019 (COVID-19) was classified as a pandemic by the World Health Organization (WHO) in March 2020. The SARS-COV-2 virus is easily transmissible and there is currently no approved treatment with effective results. Although the main epidemiological parameter…
Sponsor: Hospital Son Llatzer • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for lung cancer: experimental drug AB-106 targets ROS1 tumors
Disease control OngoingThe purpose of the study is to evaluate safety, pharmacokinetics and efficacy of AB-106 monotherapy in the treatment of advanced NSCLC.
Phase 2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for kids with rare leukemia: bosutinib trial underway
Disease control OngoingThis is a Phase 1-2, multicenter, international, single-arm, open-label study designed to identify a recommended dose of bosutinib administered orally once daily in pediatric patients with newly diagnosed chronic phase Ph+ CML (ND CML) and pediatric patients with Ph+CML who have …
Phase 1/2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
Can telemedicine bring IV antibiotics home?
Disease control OngoingThe purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the …
Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New heart valve device tested in 200 patients
Disease control OngoingA post-market study of the Edwards SAPIEN 3 Ultra System in subjects with symptomatic, severe, calcific aortic stenosis.
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New surgery technique could improve survival in recurrent throat cancer
Disease control Recruiting nowThis study aims at exploring whether plasma radiofrequency ablation at low temperature is associated with better survival outcome in localized recurrent nasopharyngeal carcinoma by conducting a randomized controlled trial of plasma radiofrequency ablation at low temperature versu…
Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New staggered drug combo aims to outsmart lung cancer
Disease control Stopped earlyThis is a Phase II, open label, randomized study of durvalumab in combination with pemetrexed and carboplatin in eligible adult patients with locally advanced or metastatic non-small cell lung cancer. The study will focus on the efficacy of two alternative staggered dosing regime…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug targets genetic kidney disease in small trial
Disease control CompletedThis study will evaluate the efficacy, safety and pharmacokinetics (PK) of VX-147 in participants with apolipoprotein L1 (APOL1)-mediated focal segmental glomerulosclerosis (FSGS).
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can nivolumab rescue patients when CAR T-Cell therapy fails?
Disease control CompletedThis phase II trial studies how well nivolumab works for the treatment of hematological malignancies that have come back (relapsed), does not respond (refractory), or is detectable after CAR T cell therapy. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Gene therapy for rare blood disease passes 15-Year safety watch
Disease control OngoingThis is a long-term safety and efficacy follow-up study for subjects with Fanconi Anaemia Subtype A who have been treated with ex vivo gene therapy on the FANCOLEN-I trial. After completion of the FANCOLEN-I study, eligible subjects will be followed for a total of 15 years post g…
Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could hepatitis c kidneys be safe for transplant?
Disease control OngoingTo determine the efficacy and safety of transplanting HCV positive kidney allografts to HCV sero-negative patients who are on the waiting list.
Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Pompe disease may raise risk of brain aneurysms, new study investigates
Knowledge-focused CompletedLate-onset Pompe disease (LOPD) is an inherited metabolic disorder caused by deficiency of acid alpha-glucosidase (GAA). In addition to skeletal and respiratory muscle involvement, previous studies suggest that patients with LOPD may have an increased frequency of cerebrovascular…
Sponsor: Hospitales Universitarios Virgen del Rocío • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Simple Face-Down position may keep COVID-19 patients off ventilators
Symptom relief CompletedAcute Respiratory Distress Syndrome (ARDS) induces high mortality, particularly in the context of COVID-19 disease. Preliminary data from patients with ARDS related to COVID-19 disease appear to show significant effectiveness of prone positioning in intubated patients in terms of…
Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Proton vs. photon: which radiation works better for leptomeningeal metastases?
Disease control CompletedThe investigators are doing this study to find out whether proton craniospinal radiation therapy (proton CSI) or partial photon radiation therapy is more effective at preventing leptomeningeal metastasis from worsening. The proton CSI targets the entire space containing the CSF, …
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI eye scan could spot hidden diseases
Diagnosis CompletedOculomics is an emerging interdisciplinary field that deciphers multi-dimensional, high-throughput ocular data to predict, diagnose, and monitor systemic diseases and health span.In recent years, artificial Intelligence may provide insight into exploring the potential covert asso…
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Can steroids help cancer patients resume a promising therapy?
Disease control Recruiting nowI238A: The purpose of this study is to find out what effects being treated with durvalumab has on cancer. The researchers doing this study also want to evaluate if prednisone (a type of steroid), when given together with durvalumab, can reduce any side effects. I238B: The purpos…
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Blood test may spare some colon cancer patients from chemo
Knowledge-focused Recruiting nowPatients in the Prospective Dutch ColoRectal Cancer cohort (PLCRC) with non-metastatic colon cancer that gave consent for additional blood withdrawals are enrolled in the observational PLCRC-MEDOCC substudy. In this study, blood is collected before surgery, after surgery and duri…
Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Can tracking brain changes over time unlock the secrets of frontotemporal dementia?
Knowledge-focused Recruiting nowARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyon…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Could a workout routine boost recovery from addiction?
Disease control Recruiting nowIn 2017, structured physical exercise with high intensity was implemented as a part of the treatment program at St. Olav Hospital Clinic of Substance Use and Addiction Medicine. The objective of this study is to examine whether implementing structured physical exercise in the tr…
Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New quick-dissolve film may tame bipolar agitation in minutes
Symptom relief CompletedThis is a definitive study to support the safety and efficacy evaluation of BXCL501 for the acute treatment of agitation in bipolar disorder. The BXCL501-302 study is designed to characterize the efficacy, safety and tolerability of BXCL501 (sublingual film formulation of DEX, HC…
Phase 3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC